SINGLE ANTIPLATELET THERAPY
Clinical trials for SINGLE ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new SINGLE ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for SINGLE ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study tests whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as two blood thinners (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 p…
Matched conditions: SINGLE ANTIPLATELET THERAPY
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Heart stent patients get personalized blood thinner dosing in new study
Disease control Recruiting nowThis study looks for the best type and dose of a single blood thinner (P2Y12 inhibitor) for people who have had a heart stent placed. About 355 participants will try different doses to find the sweet spot that prevents blood clots without causing dangerous bleeding. The goal is t…
Matched conditions: SINGLE ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 20, 2026 11:55 UTC